An Investigator Initiated, Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of Glycopyrrolate/Formoterol on Exercise Tolerance and Dynamic Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease.
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2017
At a glance
- Drugs Formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 10 Apr 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Dec 2018.
- 10 Apr 2017 Status changed from not yet recruiting to recruiting.
- 20 Mar 2017 New trial record